Immediate withdrawal from chronic "binge" cocaine administration increases mu-opioid receptor mRNA levels in rat frontal cortex. 2005

Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10021, USA. baileya@rockefeller.edu

An increase in preprodynorphin (ppdyn) mRNA was detected in the caudate putamen of chronically cocaine-treated and 3-h withdrawn rats. An increase in mu-opioid receptor (MOP) mRNA levels was observed in the frontal cortex of 3-h withdrawn rats. Naloxone had no effect on the increase of MOP or ppdyn mRNA levels. The results indicate that the opioid system is altered during early withdrawal from chronic cocaine administration.

UI MeSH Term Description Entries
D008297 Male Males
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D011498 Protein Precursors Precursors, Protein
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D005625 Frontal Lobe The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus. Brodmann Area 8,Brodmann's Area 8,Frontal Cortex,Frontal Eye Fields,Lobus Frontalis,Supplementary Eye Field,Area 8, Brodmann,Area 8, Brodmann's,Brodmanns Area 8,Cortex, Frontal,Eye Field, Frontal,Eye Field, Supplementary,Eye Fields, Frontal,Frontal Cortices,Frontal Eye Field,Frontal Lobes,Lobe, Frontal,Supplementary Eye Fields

Related Publications

Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
January 1999, Brain research bulletin,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
March 1998, Canadian journal of physiology and pharmacology,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
November 1995, Brain research. Molecular brain research,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
May 2003, Brain research. Molecular brain research,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
September 2007, Journal of neurochemistry,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
February 2008, Neuropharmacology,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
January 2005, Neuroscience,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
January 2007, Synapse (New York, N.Y.),
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
May 1996, Brain research. Molecular brain research,
Alexis Bailey, and Vadim Yuferov, and Jacob Bendor, and Stefan D Schlussman, and Yan Zhou, and Ann Ho, and Mary Jeanne Kreek
November 2014, Scientific reports,
Copied contents to your clipboard!